VisExcell
Developing better computer-aided detection in mammograms and other imaging modalities.
| Date | Investors | Amount | Round |
|---|---|---|---|
$750k | Seed | ||
| Total Funding | 000k | ||
Related Content
VisExcell, founded in 2015, operated in the healthcare technology sector with a focus on oncology diagnostics. The company developed an imaging system powered by artificial intelligence aimed at improving the detection of breast cancer.
The core of VisExcell's business was a platform that utilized computer-aided detection for mammograms and other medical imaging modalities. This technology was designed to assist physicians and radiologists by identifying potentially carcinogenic cells during routine screenings, thereby facilitating earlier and more accurate diagnoses. The company targeted healthcare providers and diagnostic imaging centers as its primary client base.
The company's journey included an initial funding round from an accelerator program on October 26, 2015, which raised $50,000. This was followed by an early-stage venture capital round in March 2016. Operating within the Artificial Intelligence & Machine Learning, Life Sciences, and Oncology verticals, VisExcell was headquartered in Ardmore, Pennsylvania. According to available data, the company ceased operations around December 31, 2021.
Keywords: medical imaging, artificial intelligence, oncology diagnostics, breast cancer detection, computer-aided detection, healthcare technology, mammography analysis, life sciences, diagnostic software, medtech